SCHEMBL14406483

SCHEMBL14406483

CCCCS(=O)(=O)N1CCN(c2nc(-c3ccccc3ON)nc3cc(Cl)ccc23)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 10/20 0.51
CNR1 P21554 2/20 0.46
CNR2 P34972 2/20 0.46
MAPT P10636 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HDAC3 O15379 1/20 0.39
MTOR P42345 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
USP2 O75604 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPK1 P28482 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
FNTA P49354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084350 0.89 MAPT (0.55) GBA1CNR1CNR2MAPTALDH1A1
SCHEMBL1084879 0.87 MEN1 (0.49) GBA1CNR1CNR2MAPTALDH1A1
SCHEMBL1084956 0.82 MAPT (0.55) GBA1CNR1CNR2MAPTALDH1A1
SCHEMBL1084751 0.79 MAPT (0.47) GBA1CNR1CNR2MAPT
SCHEMBL1084897 0.79 CYP1A2 (0.45) GBA1CNR1CNR2MAPTCYP1A2
SCHEMBL1084421 0.78 GBA1 (0.42) GBA1CNR1CNR2
SCHEMBL1084799 0.77 MEN1 (0.50) GBA1CNR1CNR2MAPTALDH1A1
SCHEMBL1084617 0.75 GBA1 (0.46) GBA1CNR1CNR2MAPTALDH1A1
SCHEMBL1084402 0.75 GBA1 (0.44) GBA1CNR1CNR2
SCHEMBL1084608 0.75 GBA1 (0.48) GBA1CNR1CNR2MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed